Delivery Order SPE2DB24D1205-SPE2DB24FCUGZ

Award Date 9/3/24
Potential Completion Date 9/4/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion (60s) to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,973.81 and a completion date of December 1, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract, valued at $1,922.86, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2024. The contract has a firm fixed price and an ultimate completion date of September 25, 2024. This is a delivery order contract, and there is no set-aside designation noted. Amerisourcebergen has been awarded numerous federal contracts,...
This federal contract award is for $7,424.52 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA). The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999, which serves as a primary vehicle for supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 25, 2024, with a ceiling value of $2,785.80 and a completion date of November 26, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA) under a firm-fixed-price delivery order. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and has a ceiling value of $9,057.01. The contract has an ultimate completion date of October 8, 2024. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the...
This federal contract award is for the delivery of cyclosporine 0.05% eye emulsion 60s to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, in the amount of $4,114.03 on May 6, 2025. The contract has a firm fixed price and an ultimate completion date of May 7, 2025. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that...
This federal contract award is for the delivery of 4566305582 Cyclosporine 0.05% eye emulsion in 60 count packages. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,888.00 and a completion date of November 4, 2024. It is a Delivery Order under a Firm Fixed Price contract type. The contract is not designated with a...
This federal contract award is for the delivery of cyclosporine 0.05% eye emulsion, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $14,596.24 and a period of performance ending on January 14, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a...
This federal contract award is for the delivery of Cyclosporine 0.05% Eye Emulsion to the Defense Logistics Agency (DLA). The contract, valued at $1,175.64, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which was previously awarded to Cencora, Inc. and runs through December 2025. This IDC serves as the primary...
  • SPE2DB24D1205
    Indefinite Delivery Contract
  • SPE2DB24D1205-SPE2DB24FCUGZ
    Delivery Order

This federal contract award is for the delivery of Cyclosporine 0.05% eye emulsion to the Defense Logistics Agency (DLA), a major defense agency. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, which is a prominent pharmaceutical distributor and supplier to the U.S. federal government. The contract has a ceiling value of $14,367.91 and is a delivery order with a firm fixed price. It is not designated as a set-aside contract. The period of performance for this contract extends until September 4, 2024. Amerisourcebergen Drug Corp has been awarded multiple Indefinite Delivery Contracts (IDCs) by the DLA and other federal agencies, valued up to $999,999,999 and $750,000 respectively, to supply a wide range of essential pharmaceutical and medical products to support military treatment programs, veterans' healthcare, and other federal healthcare initiatives nationwide.

Generated 12/3/24, 9:49 AM